An early-biomarker algorithm predicts lethal graft-versus-host disease and survival

BACKGROUND. No laboratory test can predict the risk of nonrelapse mortality (NRM) or severe graft-versus-host disease (GVHD) after hematopoietic cellular transplantation (HCT) prior to the onset of GVHD symptoms. METHODS. Patient blood samples on day 7 after HCT were obtained from a multicenter set...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:JCI Insight
المؤلفون الرئيسيون: Hartwell, Matthew J., Özbek, Umut, Holler, Ernst, Renteria, Anne S., Major-Monfried, Hannah, Reddy, Pavan, Aziz, Mina, Hogan, William J., Ayuk, Francis, Efebera, Yvonne A., Hexner, Elizabeth O., Bunworasate, Udomsak, Qayed, Muna, Ordemann, Rainer, Wölfl, Matthias, Mielke, Stephan, Pawarode, Attaphol, Chen, Yi-Bin, Devine, Steven, Harris, Andrew C., Jagasia, Madan, Kitko, Carrie L., Litzow, Mark R., Kröger, Nicolaus, Locatelli, Franco, Morales, George, Nakamura, Ryotaro, Reshef, Ran, Rösler, Wolf, Weber, Daniela, Wudhikarn, Kitsada, Yanik, Gregory A., Levine, John E., Ferrara, James L.M.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Clinical Investigation 2017
الموضوعات:
Clinical Medicine
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5291735/
https://ncbi.nlm.nih.gov/pubmed/28194439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.89798
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة